Tumor Paint Makes Surgery Safer for Kids With Cancer
An investigational drug called Tumor Paint BLZ-100, which is derived from scorpion protein, can make cancer cells glow when injected into a vein before surgery. At Seattle Children’s Hospital, doctors and surgeons are testing the safety, dosage and side effects of the new drug in a phase I clinical trial. A glowing brain tumor is easier for surgeons to see and remove, and Tumor Paint also helps keep healthy brain tissue from being injured. Dr. Sarah Leary, a pediatric neuro-oncologist at Seattle Children’s Hospital, said, “We are thinking about brain development, and not only protecting the brain that is there but protecting the brain for what it is going to do in the decades that come.”
About Seattle Children’s
Seattle Children’s mission is to provide hope, care and cures to help every child live the healthiest and most fulfilling life possible. Together, Seattle Children’s Hospital, Research Institute and Foundation deliver superior patient care, identify new discoveries and treatments through pediatric research, and raise funds to create better futures for patients.
Ranked as one of the top children’s hospitals in the country by U.S. News & World Report, Seattle Children’s serves as the pediatric and adolescent academic medical center for Washington, Alaska, Montana and Idaho – the largest region of any children’s hospital in the country. As one of the nation's top five pediatric research centers, Seattle Children’s Research Institute is internationally recognized for its work in neurosciences, immunology, cancer, infectious disease, injury prevention and much more. Seattle Children’s Hospital and Research Foundation works with the Seattle Children’s Guild Association, the largest all-volunteer fundraising network for any hospital in the country, to gather community support and raise funds for uncompensated care and research.
For more information, visit seattlechildrens.org or follow us on Twitter, Facebook, Instagram or on our On the Pulse blog.